Xuewen Li1, Yiting Wang1, Qi Zhou2, Junqi Pan3, Jiancheng Xu1. 1. Department of Laboratory Medicine, First Hospital of Jilin University, Changchun, People's Republic of China. 2. Department of Pediatrics, First Hospital of Jilin University, Changchun, People's Republic of China. 3. Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, Victoria, Australia.
Abstract
Purpose: This study aimed to provide new biomarkers for predicting the disease course of COVID-19 by analyzing the dynamic changes of microRNA (miRNA) and its target gene expression in the serum of COVID-19 patients at different stages. Methods: Serum samples were collected from all COVID-19 patients at three time points: the acute stage, the turn-negative stage, and the recovery stage. The expression level of miRNA and the target mRNA was measured by Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR). The classification tree model was established to predict the disease course, and the prediction efficiency of independent variables in the model was analyzed using the receiver operating characteristic (ROC) curve. Results: The expression of miR-125b-5p and miR-155-5p was significantly up-regulated in the acute stage and gradually decreased in the turn-negative and recovery stages. The expression of the target genes CDH5, STAT3, and TRIM32 gradually down-regulated in the acute, turn-negative, and recovery stages. MiR-125b-5p, miR-155-5p, STAT3, and TRIM32 constituted a classification tree model with 100% accuracy of prediction and AUC >0.7 for identification and prediction in all stages. Conclusion: MiR-125b-5p, miR-155-5p, STAT3, and TRIM32 could be useful biomarkers to predict the time nodes of the acute, turn-negative, and recovery stages of COVID-19.
Purpose: This study aimed to provide new biomarkers for predicting the disease course of COVID-19 by analyzing the dynamic changes of microRNA (miRNA) and its target gene expression in the serum of COVID-19 patients at different stages. Methods: Serum samples were collected from all COVID-19 patients at three time points: the acute stage, the turn-negative stage, and the recovery stage. The expression level of miRNA and the target mRNA was measured by Quantitative Real-Time Polymerase Chain Reaction (RT-qPCR). The classification tree model was established to predict the disease course, and the prediction efficiency of independent variables in the model was analyzed using the receiver operating characteristic (ROC) curve. Results: The expression of miR-125b-5p and miR-155-5p was significantly up-regulated in the acute stage and gradually decreased in the turn-negative and recovery stages. The expression of the target genes CDH5, STAT3, and TRIM32 gradually down-regulated in the acute, turn-negative, and recovery stages. MiR-125b-5p, miR-155-5p, STAT3, and TRIM32 constituted a classification tree model with 100% accuracy of prediction and AUC >0.7 for identification and prediction in all stages. Conclusion: MiR-125b-5p, miR-155-5p, STAT3, and TRIM32 could be useful biomarkers to predict the time nodes of the acute, turn-negative, and recovery stages of COVID-19.
Authors: Satoru Kudose; Ibrahim Batal; Dominick Santoriello; Katherine Xu; Jonathan Barasch; Yonatan Peleg; Pietro Canetta; Lloyd E Ratner; Maddalena Marasa; Ali G Gharavi; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati Journal: J Am Soc Nephrol Date: 2020-07-17 Impact factor: 10.121
Authors: Marília B Visacri; Aline S Nicoletti; Eder C Pincinato; Pía Loren; Nicolás Saavedra; Kathleen Saavedra; Luis A Salazar; Patricia Moriel Journal: Biomark Med Date: 2021-11-17 Impact factor: 2.851
Authors: Ryan J Farr; Christina L Rootes; John Stenos; Chwan Hong Foo; Christopher Cowled; Cameron R Stewart Journal: PLoS One Date: 2022-04-05 Impact factor: 3.240
Authors: Martin Bernhard Müller; Max Hübner; Lei Li; Stephanie Tomasi; Valena Ließke; David Effinger; Simon Hirschberger; Kristin Pogoda; Markus Sperandio; Simone Kreth Journal: Front Immunol Date: 2022-03-24 Impact factor: 7.561